Aptar Wins CE Mark for LuerVax Vaccine Delivery System
Aptar Pharma has secured CE marking for LuerVax and its spray divider, supporting intranasal vaccine development from clinical studies through commercialisation.
Aptar Pharma LuerVax CE Marking | 15/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy